scispace - formally typeset
K

Kathy L. Sivils

Researcher at Oklahoma Medical Research Foundation

Publications -  92
Citations -  4946

Kathy L. Sivils is an academic researcher from Oklahoma Medical Research Foundation. The author has contributed to research in topics: Lupus erythematosus & Genome-wide association study. The author has an hindex of 31, co-authored 81 publications receiving 3407 citations. Previous affiliations of Kathy L. Sivils include University of Oklahoma & University of Oklahoma Health Sciences Center.

Papers
More filters
Journal ArticleDOI

Sjögren syndrome

TL;DR: Knowledge of SjS has progressed substantially, but this disease is still characterized by sicca symptoms, the systemic involvement of disease, lymphocytic infiltration to exocrine glands, the presence of anti-Ro/SSA and anti-La/SSB autoantibodies and the increased risk of lymphoma in patients with SJS.
Journal ArticleDOI

Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome.

Christopher J. Lessard, +67 more
- 01 Nov 2013 - 
TL;DR: The results highlight the importance of genes that are involved in both innate and adaptive immunity in Sjögren's syndrome, including TNFAIP3, PTTG1, PRDM1, DGKQ, FCGR2A, IRAK1BP1, ITSN2 and PHIP, among others.
Journal ArticleDOI

Transancestral mapping and genetic load in systemic lupus erythematosus

Carl D. Langefeld, +116 more
TL;DR: A large transancestral association study of SLE using Immunochip genotype data from 27,574 individuals of European, African and Hispanic Amerindian ancestry identifies both ancestry-dependent and ancestry-independent contributions to SLE risk.
Journal ArticleDOI

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)

TL;DR: This study determined disease activity levels, PASS and MCII of ESSDAI and ESSPRI, which will help designing future clinical trials in SS and the proposal is to include patients with moderate activity and define response to treatment as an improvement of E SSDAI at least three points.
Journal ArticleDOI

End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.

TL;DR: The hypothesis that the apolipoprotein L1 gene (APOL1) nephropathy risk alleles G1/G2, common in African Americans and rare in European Americans, contribute to the ethnic disparity in risk of lupus nephritis is investigated.